Uyama Y, Imaizumi Y, Watanabe M, Walsh M P
Smooth Muscle Research Group, Faculty of Medicine, University of Calgary, Alberta, Canada.
Biochem J. 1996 Oct 15;319 ( Pt 2)(Pt 2):551-8. doi: 10.1042/bj3190551.
alpha-Calponin is a thin-filament-associated protein which has been implicated in the regulation of smooth muscle contraction. Quantification of the tissue content of rat tail arterial smooth muscle revealed approximately half the amount of alpha-calponin relative to actin compared with chicken gizzard and other smooth muscles, suggesting that this tissue would be particularly suitable for investigation of the effects of exogenous alpha-calponin on the contractile properties of permeabilized muscle strips. Rat tail arterial strips demembranated with Triton X-100 retained approximately 90% of their complement of alpha-calponin, and exogenous chicken gizzard alpha-calponin (which conveniently has a slightly lower molecular mass than the rat arterial protein) bound to the permeabilized muscle, presumably through its high affinity for actin. Exogenous alpha-calponin inhibited force in demembranated muscle strips in a concentration-dependent manner when added at the peak of a submaximal Ca(2+)-induced contraction, with a half-maximal effect at approximately 3 microM alpha-calponin. Pretreatment of demembranated muscle strips with alpha-calponin inhibited subsequent force development at all concentrations of Ca2+ examined over the activation range. The inhibitory effect of alpha-calponin was shown to be Ca(2+)-independent, since exogenous alpha-calponin also inhibited force in the absence of Ca2+ in demembranated muscle strips containing thiophosphorylated myosin. Phosphorylation of alpha-calponin on Ser-175 by protein kinase C has been suggested to alleviate the inhibitory effect of alpha-calponin on smooth muscle contraction. To test this hypothesis, the effects on Ca(2+)-induced and Ca(2+)-independent contractions of demembranated muscle strips of phosphorylated alpha-calponin and three site-specific mutants of alpha-calponin (in which Ser-175 was replaced by Ala, Asp or Thr) were compared with the effects of unphosphorylated tissue-purified and recombinant wild-type alpha-calponins. The recombinant wild-type protein behaved identically to the unphosphorylated tissue-purified protein, as did the S175T mutant, which is known to bind actin with high affinity and to inhibit the actin-activated myosin MgATPase in vitro. On the other hand, phosphorylated alpha-calponin and the S175A and S175D mutants, which bind weakly to actin and have little effect on the actin-activated myosin MgATPase in vitro, failed to cause significant inhibition of force induced by Ca2+ or myosin thiophosphorylation. These results support a role for alpha-calponin in the regulation of smooth muscle contraction and indicate the functional importance of Ser-175 of alpha-calponin as a regulatory site of phosphorylation.
α-钙调蛋白是一种与细肌丝相关的蛋白质,它与平滑肌收缩的调节有关。对大鼠尾动脉平滑肌组织含量的定量分析表明,与鸡肫和其他平滑肌相比,相对于肌动蛋白,大鼠尾动脉平滑肌中α-钙调蛋白的含量约为其一半,这表明该组织特别适合用于研究外源性α-钙调蛋白对通透化肌条收缩特性的影响。用Triton X-100去膜的大鼠尾动脉肌条保留了约90%的α-钙调蛋白,外源性鸡肫α-钙调蛋白(其分子量略低于大鼠动脉蛋白)与通透化肌条结合,可能是通过其对肌动蛋白的高亲和力。当在次最大钙(Ca²⁺)诱导收缩的峰值时添加外源性α-钙调蛋白,其以浓度依赖的方式抑制去膜肌条中的张力,在约3 μM α-钙调蛋白时达到半数最大效应。用α-钙调蛋白预处理去膜肌条会抑制在整个激活范围内所检测的所有Ca²⁺浓度下随后的张力发展。α-钙调蛋白的抑制作用被证明与Ca²⁺无关,因为在外源性α-钙调蛋白存在的情况下,在含有硫代磷酸化肌球蛋白的去膜肌条中,即使没有Ca²⁺,也会抑制张力。蛋白激酶C对α-钙调蛋白丝氨酸-175位点的磷酸化作用被认为可以减轻α-钙调蛋白对平滑肌收缩的抑制作用。为了验证这一假设,将磷酸化的α-钙调蛋白和α-钙调蛋白的三个位点特异性突变体(其中丝氨酸-175被丙氨酸、天冬氨酸或苏氨酸取代)对去膜肌条中Ca²⁺诱导和Ca²⁺非依赖性收缩的影响与未磷酸化的组织纯化和重组野生型α-钙调蛋白的影响进行了比较。重组野生型蛋白的行为与未磷酸化的组织纯化蛋白相同,已知与肌动蛋白具有高亲和力并在体外抑制肌动蛋白激活的肌球蛋白MgATP酶的S175T突变体也是如此。另一方面,磷酸化的α-钙调蛋白以及与肌动蛋白结合较弱且在体外对肌动蛋白激活的肌球蛋白MgATP酶几乎没有影响的S175A和S175D突变体,未能显著抑制由Ca²⁺或肌球蛋白硫代磷酸化诱导的张力。这些结果支持了α-钙调蛋白在平滑肌收缩调节中的作用,并表明α-钙调蛋白丝氨酸-